Uncategorized

Hims & Hers Launches a New Dietary Supplement for Urinary Tract Health

Only days after Telehealth company Hims & Hers announced a focus on women’s and mental health, the company is now expanding its offering with support for urinary tract health. Core to this launch are the new D-Mannose dietary supplement powder packets, that are available on ForHers.com. “Roughly 3 or 4 in 10 women who experience an initial urinary tract infection (UTI) will…

Meet 5 Femtech Companies Graduating from Y Combinator This Week!

It’s that time of the year again… Y Combinator Demo Day. And as always we had a look through the 300+ companies, that were part of the most recent batch (S21) to see if any of them are active in the women’s health space. And indeed we found a few femtech startups, that are getting ready to pitch this week! Below is an…

Indian Femtech Startup Elda Health Raises a $1.5M Seed Round to Scale its Holistic Health Platform

Bengaluru-based femtech startup Elda Health has raised a $1.5M seed round for it’s one-stop-shop holistic health platform targeting women aged 35 and up. The platform serves as an everyday companion for women on their healthcare journey, empowering them with measurable health outcomes. Avaana Capital, Orios Ventures and Ananth Narayanan Family Office participated in the round. “Women’s health has been underserved for generations.…

Carrot Fertility Raises a $75M Series C to Invest in Product Development and International Growth

San Francisco-based global fertility benefits provider for employers and health plans Carrot Fertility has announced the closing of a $75M Series C. The round was led by Tiger Global with participation from ObriMed, F-Prime Capital, CRV, U.S. Venture Partners and Silicon Valley Bank. The company has raised a total of $115M in funding to date. Companies use Carrot to customize a fertility…

BioReference Laboratories Acquires the U.S. Ariosa Centralized Lab Prenatal Testing Business from Roche

BioReference Laboratories, an OPKO Health company, has announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million patients. GenPath, BioReference’s specialty health division, currently offers, ClariTest Core, which utilizes the same…

Women’s Health Company TherapeuticsMD Announces the Appointment of Hugh O’Dowd as President

Women’s healthcare company TherapeuticsMD has announced the appointment of Hugh O’Dowd as President. He succeeds John C.K. Milligan, IV, who the Company recently appointed as Chief Executive Officer of its vitaCare Prescription Services business. “I am delighted to welcome Hugh as President of TherapeuticsMD. Hugh has a significant operating and strategic history with both large and small pharmaceutical companies including over 20…

L’Oréal Partners with Clue to Better Understand the Relationship between Skin Health and the Menstrual Cycle

L’Oréal and period tracking app Clue have announced a new partnership to deepen knowledge on the relationship between skin health and the menstrual cycle. This collaboration bridges L’Oréal’s historic skincare expertise and beauty-tech ambitions with Clue’s leadership in reproductive health and data-driven technology. In addition, Clue will work with L’Oréal’s Active Cosmetic Division and its clinical experts to develop scientifically informed new…